Equities

All Cosmos Bio-Tech Holding Corp

4148:TAI

All Cosmos Bio-Tech Holding Corp

Actions
Basic MaterialsChemicals
  • Price (TWD)55.30
  • Today's Change1.80 / 3.36%
  • Shares traded210.33k
  • 1 Year change+38.77%
  • Beta--
Data delayed at least 20 minutes, as of Nov 15 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of TWD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments1,5711,346775
Total Receivables, Net505728458
Total Inventory5911,104844
Prepaid expenses656570
Other current assets, total86124155
Total current assets2,8183,3672,302
Property, plant & equipment, net803679629
Goodwill, net1.110.360.35
Intangibles, net9.070.480.87
Long term investments223014
Note receivable - long term------
Other long term assets8.79119.04
Total assets3,6744,1112,970
LIABILITIES
Accounts payable1318498
Accrued expenses71106101
Notes payable/short-term debt0394308
Current portion long-term debt/capital leases513123.16
Other current liabilities, total758552
Total current liabilities790682562
Total long term debt305360.50
Total debt543942311
Deferred income tax393129
Minority interest560496388
Other liabilities, total0.67----
Total liabilities1,4191,744980
SHAREHOLDERS EQUITY
Common stock640640640
Additional paid-in capital782782782
Retained earnings (accumulated deficit)1,3441,3671,096
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total(512)(422)(528)
Total equity2,2542,3671,990
Total liabilities & shareholders' equity3,6744,1112,970
Total common shares outstanding646464
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.